p16 gene therapy: A potentially efficacious modality for nasopharyngeal carcinoma

Molecular Cancer Therapeutics

Volumn 2, Issue 10, 2003, Pages 961-969

  Lee, Andrew Wing Cheong ^a,b   Li, Jian Hua ^a,b   Shi, Willa ^a,b   Li, Anna ^a,b   Ng, Emily ^a,b   Liu, Ta Jen ^c   Klamut, Henry J ^a,b   Liu, Fei Fei ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DNA FRAGMENT; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CARCINOMA; CELL CYCLE; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GENE THERAPY; GENETICS; HUMAN; KINETICS; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NASOPHARYNX TUMOR; NECROSIS; REPORTER GENE; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOMEGALOVIRUS; DNA FRAGMENTATION; FLOW CYTOMETRY; GENE THERAPY; GENES, REPORTER; HUMANS; KINETICS; MICE; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NECROSIS; NEOPLASM TRANSPLANTATION; RETINOBLASTOMA PROTEIN;

EID: 2442466567     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Yu, M. C., and Yuan, J. M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol., 12: 421-429, 2002. (Pubitemid 35370755)
2. Altun, M., Fandi, A., Dupuis, O., Cvitkovic, E., Krajina, Z., and Eschwege, F. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int. J. Radiat. Oncol. Biol. Phys., 32: 859-877, 1995.
3. Hsu, J. L. and Glaser, S. L. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol., 34: 27-53, 2000. (Pubitemid 30227315)
4. Lee, N., Xia, P., Quivey, J. M., Sultanem, K., Poon, I., Akazawa, C., Akazawa, P., Weinberg, V., and Fu, K. K. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int. J. Radiat. Oncol. Biol. Phys., 53: 12-22, 2002. (Pubitemid 34465802)
5. Chow, E., Payne, D., O'Sullivan, B., Pintilie, M., Liu, F. F., Waldron, J., Warde, P., and Cummings, B. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother. Oncol., 63: 269-274, 2002. (Pubitemid 34874554)
6. Lo, K. W. and Huang, D. P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol., 12: 451-462, 2002. (Pubitemid 35370758)
7. Serrano, M. The tumor suppressor protein p16INK4a. Exp. Cell Res., 237: 7-13, 1997.
8. Gulley, M. L., Nicholls, J. M., Schneider, B. G., Amin, M. B., Ro, J. Y., and Geradts, J. Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. Am. J. Pathol., 152: 865-869, 1998. (Pubitemid 28173346)
9. Shibosawa, E., Tsutsumi, K., Koizuka, I., Hoshikawa, M., and Takakuwa, T. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas. Laryngoscope, 110: 93-97, 2000. (Pubitemid 30046652)
10. Makitie, A., MacMillan, C., Ho, J., Shi, W., Pintilie, M., O'Sullivan, B., Payne, D., Gullane, P., and Liu, F-F. p16 alteration in human nasopharyngeal carcinoma. In: Canadian Association of Radiation Oncologists, Toronto, Ontario, October 25-27, 2002.
11. Lo, K-W., Cheung, S-T., Leong, S-F., van Hasselt, A., Tsang, Y-S., Mak, K-F., Chung, Y-F., Woo, J., Lee, J. C. K., and Huang, D. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res., 56: 2721-2725, 1996. (Pubitemid 26175726)
12. Lo, K. W., Huang, D. P., and Lau, K. M. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res., 55: 2039-2043, 1995.
13. Rocco, J. W., Li, D., Liggett, W. H., Jr., Duan, L., Saunders, J. K., Jr., Sidransky, D., and O'Malley, B. W., Jr. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. Clin. Cancer Res., 4: 1697-1704, 1998. (Pubitemid 28304731)
14. Campbell, I., Magliocco, A., Moyama, T., Zheng, C., and Xiang, J. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth. Cancer Gene Ther., 7: 1270-1278, 2000.
15. Naruse, I., Heike, Y., Hama, S., Mori, M., and Saijo, N. High concentrations of recombinant adenovirus expressing p16 gene induces apoptosis in lung cancer cell lines. Anticancer Res., 18: 4275-4282, 1998. (Pubitemid 29043645)
16. Allay, J. A., Steiner, M. S., Zhang, Y., Reed, C. P., Cockroft, J., and Lu, Y. Adenovirus p16 gene therapy for prostate cancer. World J. Urol., 18: 111-120, 2000.
17. Kobayashi, S., Shirasawa, H., Sashiyama, H., Kawahira, H., Kaneko, K., Asano, T., and Ochiai, T. P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation. Clin. Cancer Res., 5: 4182-4185, 1999. (Pubitemid 30013803)
18. Kim, M., Katayose, Y., Rojanala, L., Shah, S., Sgagias, M., Jang, L., Jung, Y. J., Lee, S. H., Hwang, S. G., and Cowan, K. H. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein. Cell Death Differ., 7: 706-711, 2000. (Pubitemid 30599251)
19. Kataoka, M., Wiehle, S., Spitz, F., Schumacher, G., Roth, J. A., and Cristiano, R. J. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells. Oncogene, 19: 1589-1595, 2000. (Pubitemid 30175681)
20. Schreiber, M., Muller, W. J., Singh, G., and Graham, F. L. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene, 18: 1663-1676, 1999. (Pubitemid 29137458)
21. Wang, G. L., Lo, K. W., Tsang, K. S., Chung, N. Y., Tsang, Y. S., Cheung, S. T., Lee, J. C., and Huang, D. P. Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma. Br. J. Cancer, 81: 1122-1126, 1999.
22. Zeng, Y. Establishment of an epithelioid cell line and a fusiform cell line from a patient with nasopharyngeal carcinoma. Sci. Sin., 21: 127, 1978.
23. Sizhong, Z., Xiukung, G., and Zeng, Y. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int. J. Cancer, 31: 587-590, 1983. (Pubitemid 13058335)
24. Zhang, W. W., Alemany, R., Wang, J., Koch, P. E., Ordonez, N. G., and Roth, J. A. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum. Gene Ther., 6: 155-164, 1995.
25. Li, J. H., Lax, S. A., Kim, J., Klamut, H., and Liu, F. F. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 43: 607-616, 1999. (Pubitemid 29107184)
26. Li, J. H., Li, P., Klamut, H., and Liu, F. F. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines. Clin. Cancer Res., 3: 507-514, 1997. (Pubitemid 27211826)
27. Schumer, M., Colombel, M. C., Sawczuk, I. S., Gobe, G., Connor, J., O'Toole, K. M., Olsson, C. A., Wise, G. J., and Buttyan, R. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol., 140: 831-838, 1992.
28. Lax, S. A., Chia, M. C., Busson, P., Klamut, H. J., and Liu, F. F. Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts. Radiother. Oncol., 61: 309-312, 2001. (Pubitemid 33127236)
29. Jin, X., Nguyen, D., Zhang, W. W., Kyritsis, A. P., and Roth, J. A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res., 55: 3250-3253, 1995.
30. Calbo, J., Marotta, M., Cascallo, M., Roig, J. M., Gelpi, J. L., Fueyo, J., and Mazo, A. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer. Cancer Gene Ther., 8: 740-750, 2001. (Pubitemid 32983130)
31. Brenner, A. J., Stampfer, M. R., and Aldaz, C. M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene, 17: 199-205, 1998. (Pubitemid 28371893)
32. Dai, C. Y. and Enders, G. H. p16 INK4a can initiate an autonomous senescence program. Oncogene, 19: 1613-1622, 2000. (Pubitemid 30200963)
33. Jarrard, D. F., Sarkar, S., Shi, Y., Yeager, T. R., Magrane, G., Kinoshita, H., Nassif, N., Meisner, L., Newton, M. A., Waldman, F. M., and Reznikoff, C. A. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res., 59: 2957-2964, 1999. (Pubitemid 29283138)
34. Steiner, M. S., Zhang, Y., Farooq, F., Lerner, J., Wang, Y., and Lu, Y. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence. Cancer Gene Ther., 7: 360-372, 2000. (Pubitemid 30210403)
35. Uhrbom, L., Nister, M., and Westermark, B. Induction of senescence in human malignant glioma cells by p16INK4A. Oncogene, 15: 505-514, 1997. (Pubitemid 27384728)
36. Wolf, J. K., Kim, T. E., Fightmaster, D., Bodurka, D., Gershenson, D. M., Mills, G., and Wharton, J. T. Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus. Gynecol. Oncol., 73: 27-34, 1999. (Pubitemid 29177595)
37. Modesitt, S. C., Ramirez, P., Zu, Z., Bodurka-Bevers, D., Gershenson, D., and Wolf, J. K. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Clin. Cancer Res., 7: 1765-1772, 2001. (Pubitemid 32708647)
38. Ghaneh, P., Greenhalf, W., Humphreys, M., Wilson, D., Zumstein, L., Lemoine, N. R., and Neoptolemos, J. P. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo . Gene Ther., 8: 199-208, 2001. (Pubitemid 32186131)
39. Qi, V., Weinrib, L., Ma, N., Li, J. H., Klamut, H., and Liu, F. F. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line. Int. J. Hyperthermia, 17: 38-47, 2001. (Pubitemid 32058481)
40. Liu, T-J., El-Naggar, A., McDonnell, T., Steck, K., Wang, M., Taylor, D., and Clayman, G. L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
41. Katayose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K., and Seth, P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res., 1: 889-897, 1995.
42. Cirielli, C., Riccioni, T., Yang, C., Pili, R., Gloe, T., Chang, J., Inyaku, K., Passaniti, A., and Capogrossi, M. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int. J. Cancer, 63: 673-679, 1995.
43. Yang, C., Cirielli, C., Capogrossi, M., and Passaniti, A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res., 55: 4120-4213, 1995.
44. Fang, X., Jin, X., Xu, H. J., Liu, L., Peng, H. Q., Hogg, D., Roth, J. A., Yu, Y., Xu, F., Bast, R. C., Jr., and Mills, G. B. Expression of p16 induces transcriptional down-regulation of the RB gene. Oncogene, 16: 1-8, 1998. (Pubitemid 28045038)
45. Morris, E. J. and Dyson, N. J. Retinoblastoma protein partners. Adv. Cancer Res., 82: 1-54, 2001. (Pubitemid 32613381)
46. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature, 375: 503-506, 1995.
47. Matsumura, Y., Yamagishi, N., Miyakoshi, J., Imamura, S., and Takebe, H. Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene. Cancer Lett., 115: 91-96, 1997. (Pubitemid 27139859)
48. Miyakoshi, J., Kitagawa, K., Yamagishi, N., Ohtsu, S., Day, R. S., 3rd, and Takebe, H. Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene. Jpn. J. Cancer Res., 88: 34-38, 1997. (Pubitemid 27096226)
49. Chow, L. S., Wang, X., Kwong, D. L., Sham, J. S., Tsao, S. W., and Nicholls, J. M. Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells. Int. J. Oncol., 17: 135-140, 2000.
50. Maity, A., McKenna, W. G., and Muschel, R. J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol., 31: 1-13, 1994. (Pubitemid 24167585)
51. Smeets, M. F., Mooren, E. H., and Begg, A. C. The effect of radiation on G2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother. Oncol., 33: 217-227, 1994.
52. Metting, N. F. and Little, J. B. Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies radiation-induced G2-phase arrest in HeLa cells. Radiat. Res., 143: 286-292, 1995.
53. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo . Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.
54. Morreau, H., Galjart, N. J., Gillemans, N., Willemsen, R., van der Horst, G. T., and d'Azzo, A. Alternative splicing of β-galactosidase mRNA generates the classic lysosomal enzyme and a β-galactosidase-related protein. J. Biol. Chem., 264: 20655-20663, 1989. (Pubitemid 20009263)
55. Rocco, J. W. and Sidransky, D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp. Cell Res., 264: 42-55, 2001. (Pubitemid 32989080)
56. Plath, T., Detjen, K., Welzel, M., von Marschall, Z., Murphy, D., Schirner, M., Wiedenmann, B., and Rosewicz, S. A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the α(5)β(1) fibronectin receptor. J. Cell Biol., 150: 1467-1478, 2000.
57. Gulley, M. L., Burton, M. P., Allred, D. C., Nicholls, J. M., Amin, M. B., Ro, J. Y., and Schneider, B. G. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum. Pathol., 29: 252-259, 1998. (Pubitemid 28123922)